3Rubin LA, Nelsson DL. The soluble interleukin-2 receptor: biology function and clinical application. Ann Intern Med. 1990, 113:619.
4Rubin LA. Soluble interleukin-2 receptors are releaced by activated human lymphoid cells in vitro. J Immunology. 1995, 135:3172.
5Robb R, Margaret R. Soluble interleukin-2 receptor inhibits interleukin-2 dependent proliferation and cytotoxicity. In Ves Dormal. 1992, 89:50.
6Robb RI. Conversion of low-affinity interleukin-2 receptors to high-affinity state following fusion of cell membercmes. Proc Natl Acand Sci USA. 1986, 83:3992.
7Verheul HA, Verveld M, Bos ES. Immunol therapy through the IL-2 receptor. Immunol Res. 1992,11(4):42.
8Sipe JD.Acute-phase proteins in osteoarthritis.Semin Arthritis Rheum,1995,25:750.
9Thompson S,Kelly CA,Griffiths ID,et al.Abnormally-fucosylated serum haptogloobins in patients with inflammatory joint disease.Clin Chim Acta,1989,184(3):251.
10Ahmadzadeh N,Shingu I,Nobunaga I.Iron-binding proteins and free iron in synovial fluids of rheumatoid arthritis patients.Clin Rheumatol,1989,8(3):345.
6Dupuy AM, Terrier N, Senecal L, et al. Is C-reactive pro-tein a marker of inflammation[ J]. Nephrologie, 2003, 24 (7) : 337-341.
7Brown DM, Rom á n E, Swain SL. CD4 T cell responses to influenza infection[J]. Semin Immunol, 2004, 16 (3): 171-177.
8Small BA, Dressel SA, Lawrence CW, et al. CD +8 T cell- mediated injury in vivo progresses in the absence of effector T cells[J]. Exp Med, 2001, 194 (12): 1835-1846.
